Cytochrome P450 2C19 poor metabolizer phenotype in treatment resistant depression: Treatment and diagnostic implications

Marin Veldic, Ahmed T. Ahmed, Caren J. Blacker, Jennifer R. Geske, Joanna M. Biernacka, Kristin L. Borreggine, Katherine M. Moore, Miguel L. Prieto, Jennifer L. Vande Voort, Paul E. Croarkin, Astrid A. Hoberg, Simon Kung, Renato D. Alarcon, Nicola Keeth, Balwinder Singh, William V. Bobo, Mark A. Frye

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

Copyright
Original languageAmerican English
JournalFrontiers in Pharmacology
Volume10
Issue numberFEB
DOIs
StatePublished - 1 Jan 2019

Keywords

  • Bipolar disorder
  • CYP2C19
  • Cytochrome P450
  • Pharmacogenomics
  • SLC6A4

Fingerprint Dive into the research topics of 'Cytochrome P450 2C19 poor metabolizer phenotype in treatment resistant depression: Treatment and diagnostic implications'. Together they form a unique fingerprint.

Cite this